Angiogenesis pioneer dies

Article

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Judah Folkman, MD, the pioneer of angiogenesis research, died on January 15th 2008.

Dr Folkman was the 2006 recipient of the Helen Keller Prize for Vision Research. His 1971 hypothesis, that solid tumours are angiogenesis-dependent, led researchers to the first angiogenic inhibitor for age-related macular degeneration (AMD), laying the groundwork for drugs such as Lucentis and Macugen.

Thanks to Dr Folkman, ten new cancer drugs are on the market and people who might otherwise be blind have been given a lifeline.

Recent Videos
David Yorston, FRCS, FRCOphth, discusses his EURETINA keynote lecture
Hoda Shamsnajafabadi, MSc, PhD, presents at the 2024 EURETINA meeting
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
Carl Awh, MD, FASRS, speaks about the American Society of Retina Specialists (ASRS) at EURETINA
Stefano Mercuri, MD, first author of the winning eposter “Genotype-phenotype correlations in a cohort of genetically determined Retinitis Pigmentosa (RP) Italian patients with Rho gene mutations”
Bahram Bodaghi, MD, PHD, FEBO at the 2024 EURETINA meeting
Enrico Borrelli, MD, FEBO, speaks at EURETINA
Aleksandra Rachitskaya, MD, FASRS, speaks about the Vit-Buckle Society at the 2024 EURETINA Congress.
Related Content
© 2024 MJH Life Sciences

All rights reserved.